Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia
- PMID:17936557
- PMCID: PMC2424201
- DOI: 10.1016/j.ccr.2007.08.020
Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia
Abstract
Although TGFbeta is a potent inhibitor of proliferation, epithelia lacking the essential receptor (TbetaRII) for TGFbeta signaling display normal tissue homeostasis. By studying asymptomatic TbetaRII-deficient stratified epithelia, we show that tissue homeostasis is maintained by balancing hyperproliferation with elevated apoptosis. Moreover, rectal and genital epithelia, which are naturally proliferative, develop spontaneous squamous cell carcinomas with age when TbetaRII is absent. This progression is associated with a reduction in apoptosis and can be accelerated in phenotypically normal epidermis by oncogenic mutations in Ras. We show that TbetaRII deficiency leads to enhanced keratinocyte motility and integrin-FAK-Src signaling. Together, these mechanisms provide a molecular framework to account for many of the characteristics of TbetaRII-deficient invasive SQCCs.
Figures







Comment in
- Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis.Wakefield LM, Stuelten C.Wakefield LM, et al.Cancer Cell. 2007 Oct;12(4):293-5. doi: 10.1016/j.ccr.2007.10.002.Cancer Cell. 2007.PMID:17936552
Similar articles
- Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis.Wakefield LM, Stuelten C.Wakefield LM, et al.Cancer Cell. 2007 Oct;12(4):293-5. doi: 10.1016/j.ccr.2007.10.002.Cancer Cell. 2007.PMID:17936552
- Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.Bharathy S, Xie W, Yingling JM, Reiss M.Bharathy S, et al.Cancer Res. 2008 Mar 15;68(6):1656-66. doi: 10.1158/0008-5472.CAN-07-5089.Cancer Res. 2008.PMID:18339844Free PMC article.
- Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.Cohen J, Chen Z, Lu SL, Yang XP, Arun P, Ehsanian R, Brown MS, Lu H, Yan B, Diallo O, Wang XJ, Van Waes C.Cohen J, et al.Cancer Res. 2009 Apr 15;69(8):3415-24. doi: 10.1158/0008-5472.CAN-08-3704. Epub 2009 Apr 7.Cancer Res. 2009.PMID:19351843Free PMC article.
- Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.Moses MA, George AL, Sakakibara N, Mahmood K, Ponnamperuma RM, King KE, Weinberg WC.Moses MA, et al.Int J Mol Sci. 2019 Jul 23;20(14):3590. doi: 10.3390/ijms20143590.Int J Mol Sci. 2019.PMID:31340447Free PMC article.Review.
- TGFBR1 and cancer susceptibility.Pasche B, Pennison MJ, Jimenez H, Wang M.Pasche B, et al.Trans Am Clin Climatol Assoc. 2014;125:300-12.Trans Am Clin Climatol Assoc. 2014.PMID:25125747Free PMC article.Review.
Cited by
- Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway.French D, Belleudi F, Mauro MV, Mazzetta F, Raffa S, Fabiano V, Frega A, Torrisi MR.French D, et al.Mol Cancer. 2013 May 7;12:38. doi: 10.1186/1476-4598-12-38.Mol Cancer. 2013.PMID:23651589Free PMC article.
- Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells.Mou H, Vinarsky V, Tata PR, Brazauskas K, Choi SH, Crooke AK, Zhang B, Solomon GM, Turner B, Bihler H, Harrington J, Lapey A, Channick C, Keyes C, Freund A, Artandi S, Mense M, Rowe S, Engelhardt JF, Hsu YC, Rajagopal J.Mou H, et al.Cell Stem Cell. 2016 Aug 4;19(2):217-231. doi: 10.1016/j.stem.2016.05.012. Epub 2016 Jun 16.Cell Stem Cell. 2016.PMID:27320041Free PMC article.
- Targeted deletion of TGFβ1 in basal keratinocytes causes profound defects in stratified squamous epithelia and aberrant melanocyte migration.Chalmers FE, Dusold JE, Shaik JA, Walsh HA, Glick AB.Chalmers FE, et al.Dev Biol. 2022 May;485:9-23. doi: 10.1016/j.ydbio.2022.02.009. Epub 2022 Feb 25.Dev Biol. 2022.PMID:35227671Free PMC article.
- Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.Hannigan A, Smith P, Kalna G, Lo Nigro C, Orange C, O'Brien DI, Shah R, Syed N, Spender LC, Herrera B, Thurlow JK, Lattanzio L, Monteverde M, Maurer ME, Buffa FM, Mann J, Chu DC, West CM, Patridge M, Oien KA, Cooper JA, Frame MC, Harris AL, Hiller L, Nicholson LJ, Gasco M, Crook T, Inman GJ.Hannigan A, et al.J Clin Invest. 2010 Aug;120(8):2842-57. doi: 10.1172/JCI36125. Epub 2010 Jul 1.J Clin Invest. 2010.PMID:20592473Free PMC article.
- FOXO1 promotes wound healing through the up-regulation of TGF-β1 and prevention of oxidative stress.Ponugoti B, Xu F, Zhang C, Tian C, Pacios S, Graves DT.Ponugoti B, et al.J Cell Biol. 2013 Oct 28;203(2):327-43. doi: 10.1083/jcb.201305074. Epub 2013 Oct 21.J Cell Biol. 2013.PMID:24145170Free PMC article.
References
- Amendt C, Schirmacher P, Weber H, Blessing M. Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene. 1998;17:25–34. - PubMed
- Amendt C, Mann A, Schirmacher P, Blessing M. Resistance of keratinocytes to TGFβ-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. J Cell Sci. 2002;115:2189–2198. - PubMed
- Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol. 1999;1:260–266. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous